更多开发者作品
The Lancet Respiratory Medicine
| 1. | [Correspondence] Further insights into MARS 2 | Yumna Ahmed, Agha Muhammad Hammad Khan, Calogero Casa, Ahmed Nadeem Abbasi | |
| 2. | [Correspondence] Further insights into MARS 2 | Peter Zhan, Daniel J Boffa, Gavitt A Woodard | |
| 3. | [Correspondence] Further insights into MARS 2 | Marcello Migliore | |
| 4. | [Correspondence] Further insights into MARS 2 – Authors' reply | Eric Lim, Chris Rogers, MARS 2 trialists | |
| 5. | [Editorial] FLiRTing with danger as SARS-CoV-2 variants evolve | The Lancet Respiratory Medicine | |
| 6. | [Comment] Patient-reported outcomes: missing in asthma remission | Amy Hai Yan Chan, Paul Leong, John Politis, Vanessa M McDonald, Philip Bardin | |
| 7. | [Articles] Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study | Margaux M I Meslé, Jeremy Brown, Piers Mook, Mark A Katz, José Hagan, Roberta Pastore, Bernhard Benka, Monika Redlberger-Fritz, Nathalie Bossuyt, Veerle Stouten, Catharina Vernemmen, Elisabet Constantinou, Marek Maly, Jan Kynčl, Ondrej Sanca, Tyra Grove Krause, Lasse Skafte Vestergaard, Tuija Leino, Eero Poukka, Kassiani Gkolfinopoulou, Kassiani Mellou, Maria Tsintziloni, Zsuzsanna Molnár, Gudrun Aspelund, Marianna Thordardottir, Lisa Domegan, Eva Kelly, Joan O’Donell, Alberto-Mateo Urdiales, Flavia Riccardo, Chiara Sacco, Viktoras Bumšteinas, Rasa Liausediene, Joël Mossong, Anne Vergison, Maria-Louise Borg, Tanya Melillo, Dragan Kocinski, Enkela Pollozhani, Hinta Meijerink, Diana Costa, João Paulo Gomes, Pedro Pinto Leite, Alina Druc, Veaceslav Gutu, Valentin Mita, Mihaela Lazar, Rodica Popescu, Odette Popovici, Monika Musilová, Maja Mrzel, Maja Socan, Veronika Učakar, Aurora Limia, Clara Mazagatos, Carmen Olmedo, Gavin Dabrera, Meaghan Kall, Mary Sinnathamby, Graham McGowan, Jim McMenamin, Kirsty Morrison, Dorit Nitzan, Marc-Alain Widdowson, Catherine Smallwood, Richard Pebody, WHO European Respiratory Surveillance Network | |
| 8. | [Comment] Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned | Oliver J Watson, Alexandra B Hogan | |
| 9. | [News] US FDA approves menthol e-cigarette products | Bryant Furlow | |
| 10. | [Articles] Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study | Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, Mingjun Li, Zhiye Zhang, Ying Cheng, Yun Fan, Hongming Pan, Baoqing Wang, Gongyan Chen, Ke Wang, Liyan Jiang, Yanping Hu, Jianhua Shi, Xiaorong Dong, Cuimin Ding, Yunpeng Liu, Zhe Liu, Wangjun Liao, Wei Li, Jun Wang, Shanyong Yi, Qiong Zhao, Aimin Zang, Yuan Chen, Jiuwei Cui, Pengfei Luo, Xionghu Shen, Meili Sun, Changli Wang, Yi-Long Wu, SAF001 study group | |
| 11. | [Comment] Foritinib, a type II ROS1 inhibitor for NSCLC | Jii Bum Lee, Sai-Hong Ignatius Ou | |
| 12. | [News] US Supreme Court overturns Chevron doctrine | Bryant Furlow | |
| 13. | [Review] Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients | Simon Feys, Agostinho Carvalho, Cornelius J Clancy, Jean-Pierre Gangneux, Martin Hoenigl, Katrien Lagrou, Bart J A Rijnders, Laura Seldeslachts, Lore Vanderbeke, Frank L van de Veerdonk, Paul E Verweij, Joost Wauters | |
| 14. | [Articles] Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation | Hernan P Fainberg, Yuben Moodley, Isaac Triguero, Tamera J Corte, Jannie M B Sand, Diana J Leeming, Morten A Karsdal, Athol U Wells, Elisabetta Renzoni, John Mackintosh, Dino B A Tan, Roger Li, Joanne Porte, Rebecca Braybrooke, Gauri Saini, Simon R Johnson, Louise V Wain, Philip L Molyneaux, Toby M Maher, Iain D Stewart, R Gisli Jenkins | |
| 15. | [Comment] Biomarker-defined endotypes of pulmonary fibrosis | A Scott McCall, Jonathan A Kropski | |
| 16. | [Spotlight] Alin Gragossian: from emergency medicine resident to heart transplant recipient | Tony Kirby | |
| 17. | [Spotlight] Fasting in Ramadan and respiratory diseases | Talha Burki | |
| 18. | [Articles] Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial | The HYPOREME Trial Group | |
| 19. | [Comment] Mild hypothermia for expanded criteria kidney donors: balancing evidence and uncertainty | Riccardo Campi, Vincenzo Li Marzi, Sergio Serni | |
| 20. | [Articles] Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial | Claire Elizabeth Wainwright, Suzanna Vidmar, Vicki Anderson, Pierrick Bourgeat, Catherine Byrnes, John Brooke Carlin, Joyce Cheney, Peter Cooper, Andrew Davidson, Nicholas Gailer, Jasmin Grayson-Collins, Alexandra Quittner, Colin Robertson, Olivier Salvado, Diana Zannino, Floyd Daniel Armstrong, ACFBAL, CF-GAIN Study Groups | |
| 21. | [Comment] Early exposure to general anaesthesia: considerations for age-related vulnerability and behavioural outcomes | Daniil P Aksenov | |
更新于 57 分钟前
近期历史最近 100 条记录
| 2024-08-29 | [Correspondence] Further insights into MARS 2 | Yumna Ahmed, Agha Muhammad Hammad Khan, Calogero Casa, Ahmed Nadeem Abbasi | |
| 2024-08-29 | [Correspondence] Further insights into MARS 2 | Peter Zhan, Daniel J Boffa, Gavitt A Woodard | |
| 2024-08-29 | [Correspondence] Further insights into MARS 2 | Marcello Migliore | |
| 2024-08-29 | [Correspondence] Further insights into MARS 2 – Authors' reply | Eric Lim, Chris Rogers, MARS 2 trialists | |
| 2024-08-29 | [Editorial] FLiRTing with danger as SARS-CoV-2 variants evolve | The Lancet Respiratory Medicine | |
| 2024-08-29 | [Comment] Patient-reported outcomes: missing in asthma remission | Amy Hai Yan Chan, Paul Leong, John Politis, Vanessa M McDonald, Philip Bardin | |
| 2024-08-29 | [Articles] Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study | Margaux M I Meslé, Jeremy Brown, Piers Mook, Mark A Katz, José Hagan, Roberta Pastore, Bernhard Benka, Monika Redlberger-Fritz, Nathalie Bossuyt, Veerle Stouten, Catharina Vernemmen, Elisabet Constantinou, Marek Maly, Jan Kynčl, Ondrej Sanca, Tyra Grove K | |
| 2024-08-29 | [Comment] Impact of COVID-19 vaccination programmes in Europe: lives saved and lessons learned | Oliver J Watson, Alexandra B Hogan | |
| 2024-08-29 | [News] US FDA approves menthol e-cigarette products | Bryant Furlow | |
| 2024-08-29 | [Comment] Foritinib, a type II ROS1 inhibitor for NSCLC | Jii Bum Lee, Sai-Hong Ignatius Ou | |
| 2024-08-29 | [Articles] Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 study | Jin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, Mingjun Li, Zhiye Zhang, Ying Cheng, Yun Fan, Hongming Pan, Baoqing Wang, Gongyan Chen, Ke Wang, Liyan Jiang, Yanping Hu, Jianhua Shi, Xiaorong Dong, Cuimin Ding, Yunpeng Liu, Zhe Liu, Wangjun Liao, Wei Li, | |
| 2024-08-29 | [News] US Supreme Court overturns Chevron doctrine | Bryant Furlow | |
| 2024-08-29 | [Articles] Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation | Hernan P Fainberg, Yuben Moodley, Isaac Triguero, Tamera J Corte, Jannie M B Sand, Diana J Leeming, Morten A Karsdal, Athol U Wells, Elisabetta Renzoni, John Mackintosh, Dino B A Tan, Roger Li, Joanne Porte, Rebecca Braybrooke, Gauri Saini, Simon R Johnso | |
| 2024-08-29 | [Review] Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients | Simon Feys, Agostinho Carvalho, Cornelius J Clancy, Jean-Pierre Gangneux, Martin Hoenigl, Katrien Lagrou, Bart J A Rijnders, Laura Seldeslachts, Lore Vanderbeke, Frank L van de Veerdonk, Paul E Verweij, Joost Wauters | |
| 2024-08-29 | [Comment] Biomarker-defined endotypes of pulmonary fibrosis | A Scott McCall, Jonathan A Kropski | |
| 2024-08-29 | [Spotlight] Alin Gragossian: from emergency medicine resident to heart transplant recipient | Tony Kirby | |
| 2024-08-29 | [Spotlight] Fasting in Ramadan and respiratory diseases | Talha Burki | |
| 2024-08-29 | [Articles] Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial | The HYPOREME Trial Group | |
| 2024-08-29 | [Comment] Mild hypothermia for expanded criteria kidney donors: balancing evidence and uncertainty | Riccardo Campi, Vincenzo Li Marzi, Sergio Serni | |
| 2024-08-29 | [Articles] Long-term outcomes of early exposure to repeated general anaesthesia in children with cystic fibrosis (CF-GAIN): a multicentre, open-label, randomised controlled phase 4 trial | Claire Elizabeth Wainwright, Suzanna Vidmar, Vicki Anderson, Pierrick Bourgeat, Catherine Byrnes, John Brooke Carlin, Joyce Cheney, Peter Cooper, Andrew Davidson, Nicholas Gailer, Jasmin Grayson-Collins, Alexandra Quittner, Colin Robertson, Olivier Salvad | |
| 2024-08-29 | [Comment] Early exposure to general anaesthesia: considerations for age-related vulnerability and behavioural outcomes | Daniil P Aksenov | |
| 2024-07-31 | [Correspondence] The recent explosion in snortable energy powder consumption | Jérémie Pourchez, Clément Mercier, Lara Leclerc, Valérie Forest | |
| 2024-07-31 | [Editorial] Household air pollution: a neglected threat | The Lancet Respiratory Medicine | |
| 2024-07-31 | [Correspondence] Concerning the use of aminoglycosides in ventilator-associated pneumonia | Simone Y M de Jong, G Jan Zijlstra | |
| 2024-07-31 | [Correspondence] Concerning the use of aminoglycosides in ventilator-associated pneumonia – Authors' reply | Srishti Chhabra, Yin Mo | |
| 2024-07-31 | [Corrections] Correction to Lancet Respir Med 2024; 12: 642–54 | | |
| 2024-07-31 | [Articles] Nasal sprays and behavioural interventions compared with usual care for acute respiratory illness in primary care: a randomised, controlled, open-label, parallel-group trial | Paul Little, Jane Vennik, Kate Rumsby, Beth Stuart, Taeko Becque, Michael Moore, Nick Francis, Alastair D Hay, Theo Verheij, Katherine Bradbury, Kate Greenwell, Laura Dennison, Sian Holt, James Denison-Day, Ben Ainsworth, James Raftery, Tammy Thomas, Chri | |
| 2024-07-31 | [Comment] Treating acute respiratory illness: the need to be proactive | Evangelos J Giamarellos-Bourboulis | |
| 2024-07-31 | [News] Whooping cough cases rising | Priya Venkatesan | |
| 2024-07-31 | [Correspondence] Potential for personalised and biomarker-guided COPD self-treatment approaches | Anke Lenferink, Emanuel Citgez, Paul D L P M van der Valk, Job van der Palen, Tanja W Effing, Marjolein G J Brusse-Keizer | |
| 2024-07-31 | [Comment] Moving forward in IPF: lessons learned from clinical trials | Ganesh Raghu, Thomas R Fleming | |
| 2024-07-31 | [Correspondence] Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials | Brady Thomas, Patrick McNamara, Jennifer Bermick | |
| 2024-07-31 | [Correspondence] Challenges of modulating the risk of bronchopulmonary dysplasia in clinical trials – Authors' reply | John Lowe, Janet Berrington, David Gillespie, Mark Turner, Sailesh Kotecha | |
| 2024-07-31 | [News] 2024 American Thoracic Society International Conference | Priya Venkatesan | |
| 2024-07-31 | [Articles] Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial | Ziming Li, Xiaomin Dang, Dingzhi Huang, Shi Jin, Weiwei Li, Jianhua Shi, Xicheng Wang, Yiping Zhang, Zhengbo Song, Junping Zhang, Wu Zhuang, Xuewen Liu, Liyan Jiang, Xiangjiao Meng, Mingfang Zhao, Jianying Zhou, Liangming Zhang, Pingli Wang, Hui Luo, Junq | |
| 2024-07-31 | [Comment] Tackling KRASG12C-mutated non-small-cell lung cancer: iteration and exploration | Jia Luo, Liza C Villaruz | |
| 2024-07-31 | [Personal View] When to intubate in acute hypoxaemic respiratory failure? Options and opportunities for evidence-informed decision making in the intensive care unit | Kevin G Lee, Oriol Roca, Jonathan D Casey, Matthew W Semler, Georgiana Roman-Sarita, Christopher J Yarnell, Ewan C Goligher | |
| 2024-07-31 | [Comment] Overcoming barriers to scaling up tuberculosis preventive treatment for household contacts | Gavin Churchyard, Nicole Salazar-Austin | |
| 2024-07-31 | [Articles] Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies | Leonardo Martinez, James A Seddon, C Robert Horsburgh, Christoph Lange, Anna M Mandalakas, TB Contact Studies Consortium | |
| 2024-07-31 | [Comment] Treatment effects on functional outcomes in trials with severely ill patients | Edmond S W Ng | |
| 2024-07-31 | [Articles] Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial | Matthew F Mart, Leanne M Boehm, Amy L Kiehl, Michelle N Gong, Atul Malhotra, Robert L Owens, Babar A Khan, Margaret A Pisani, Gregory A Schmidt, R Duncan Hite, Matthew C Exline, Shannon S Carson, Catherine L Hough, Peter Rock, Ivor S Douglas, Daniel J Fei | |
| 2024-07-31 | [Articles] Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a multicentre, double-blind, randomised, placebo-controlled trial | John Lowe, David Gillespie, Ali Aboklaish, Tin Man Mandy Lau, Claudia Consoli, Malavika Babu, Mark Goddard, Kerenza Hood, Nigel Klein, Emma Thomas-Jones, Mark Turner, Marie Hubbard, Julian Marchesi, Janet Berrington, Sailesh Kotecha | |
| 2024-07-31 | [Comment] Azithromycin for the prevention of chronic lung disease of prematurity: not a silver bullet | Abdul Razak | |
| 2024-06-26 | [Corrections] Correction to Lancet Respir Med 2024; 12: 544–55 | | |
| 2024-06-26 | [Spotlight] Protecting respiratory health of athletes: an Olympic challenge | James H Hull, Hege Clemm, Vibeke Backer, Michael Koehle, Margo Mountjoy, Martin Schwellnus, J Tod Olin | |
| 2024-06-26 | [Spotlight] Living with spinal muscular atrophy while working in critical care | Linsey Wehner, Atul Malhotra, Jeremy Orr | |
| 2024-06-26 | [Editorial] Respiratory syncytial virus vaccines: the future is bright | The Lancet Respiratory Medicine | |
| 2024-06-26 | [Articles] High-flow nasal oxygen for children's airway surgery to reduce hypoxaemic events: a randomised controlled trial | Susan Humphreys, Britta S von Ungern-Sternberg, Fiona Taverner, Andrew Davidson, Justin Skowno, Ben Hallett, David Sommerfield, Neil Hauser, Tara Williams, Susan Spall, Trang Pham, Tiffany Atkins, Mark Jones, Emma King, Laura Burgoyne, Philip Stephens, Sh | |
| 2024-06-26 | [Corrections] Correction to Lancet Respir Med 2024; 12: 207–16 | | |
| 2024-06-26 | [Corrections] Correction to Lancet Respir Med 2024; 12: 183–85 | | |
| 2024-06-26 | [Comment] Paediatric anaesthesia: it is not only what you do, but how you do it | Thomas Engelhardt, Nicola Disma | |
| 2024-06-26 | [Comment] Continuous positive airway pressure is here to stay | Atul Malhotra, Jeremy H Pettus | |
| 2024-06-26 | [Comment] Re-evaluating the role of CPAP in OSA management amid obesity pharmacology advancements | Neomi Shah | |
| 2024-06-26 | [Articles] Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial | Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty, Raymond L Benza, Richard N Channick, Kelly M Chin, Anna R Hemnes, Luke S Howard, Olivier Sitbon, Jean-Luc Vachiéry, Roham T Zamanian, Matt Cravets, Robert F Ros | |
| 2024-06-26 | [Personal View] Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally | Anne B Chang, Tom Kovesi, Gregory J Redding, Conroy Wong, Gonzalo G Alvarez, Rebecca Nantanda, Edgar Beltetón, Maynor Bravo-López, Maree Toombs, Paul J Torzillo, Diane M Gray | |
| 2024-06-26 | [Articles] Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo | Sascha Meyer, Johannes Bay, Axel R Franz, Harald Ehrhardt, Lars Klein, Jutta Petzinger, Christoph Binder, Susanne Kirschenhofer, Anja Stein, Britta Hüning, Axel Heep, Eva Cloppenburg, Julia Muyimbwa, Torsten Ott, Julia Sandkötter, Norbert Teig, Susanne Wi | |
| 2024-06-26 | [Comment] Vitamin A and bronchopulmonary dysplasia: the next steps | Abhijeet Rakshasbhuvankar, J Jane Pillow | |
| 2024-06-26 | [Articles] Transbronchial cryobiopsy followed by as-needed surgical lung biopsy versus immediate surgical lung biopsy for diagnosing interstitial lung disease (the COLD study): a randomised controlled trial | Kirsten A Kalverda, Maarten K Ninaber, Lizzy Wijmans, Jan von der Thüsen, René E Jonkers, Johannes M Daniels, Jelle R Miedema, Chris Dickhoff, Jürgen Hölters, David Heineman, Merijn Kant, Teodora Radonic, Ghada Shahin, Danielle Cohen, Bart Boerrigter, Suz | |
| 2024-06-26 | [Comment] Optimising the approach to ILD diagnosis: the balance of procedural complications against diagnostic accuracy | Margaret L Salisbury, Kevin R Flaherty | |
| 2024-05-30 | [Corrections] Correction to Lancet Respir Med 2021; 9: 1275–87 | | |
| 2024-05-30 | [Viewpoint] Leveraging the pleural space for anticancer therapies in pleural mesothelioma | Kevin G Blyth, Prasad S Adusumilli, Philippe Astoul, Liz Darlison, Y C Gary Lee, Aaron S Mansfield, Stefan J Marciniak, Nick Maskell, Vasiliki Panou, Tobias Peikert, Najib M Rahman, Marjorie G Zauderer, Daniel Sterman, Dean A Fennell | |
| 2024-05-30 | [Articles] Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial | Eric Lim, David Waller, Kelvin Lau, Jeremy Steele, Anthony Pope, Clinton Ali, Rocco Bilancia, Manjusha Keni, Sanjay Popat, Mary O'Brien, Nadza Tokaca, Nick Maskell, Louise Stadon, Dean Fennell, Louise Nelson, John Edwards, Sara Tenconi, Laura Socci, Rober | |
| 2024-05-30 | [Comment] MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma | Federica Grosso, Luigi Cerbone, Alessandra Curioni-Fontecedro | |
| 2024-05-30 | [Editorial] Tackling health disparities in asthma: a life-course challenge | The Lancet Respiratory Medicine | |
| 2024-05-30 | [News] US EPA confronts chemical plants’ deadly air pollution | Bryant Furlow | |
| 2024-05-30 | [News] New report outlines cost of inaction on AMR ahead of UN high-level meeting | Talha Burki | |
| 2024-05-30 | [News] European Lung Cancer Congress 2024 | Priya Venkatesan | |
| 2024-05-30 | [Comment] Realignment of clinical research after the COVID-19 era | Dennis Thomas, Vanessa M McDonald, Peter G Gibson | |
| 2024-05-30 | [Spotlight] A Monument to the Past | Talha Burki | |
| 2024-05-30 | [Articles] High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial | Rovina Ruslami, Federica Fregonese, Lika Apriani, Leila Barss, Nancy Bedingfield, Victor Chiang, Victoria J Cook, Dina Fisher, Eri Flores, Greg J Fox, James Johnston, Rachel K Lim, Richard Long, Catherine Paulsen, Thu Anh Nguyen, Nguyen Viet Nhung, Diana | |
| 2024-05-30 | [Comment] High-dose rifampicin to treat tuberculosis infection: potential and pitfalls | Theresa S Ryckman, Nicole Salazar-Austin | |
| 2024-05-30 | [Articles] Efficacy of oral corticosteroids for acute preschool wheeze: a systematic review and individual participant data meta-analysis of randomised clinical trials | Bohee Lee, Steve Turner, Meredith Borland, Péter Csonka, Jonathan Grigg, Theresa W Guilbert, Tuomas Jartti, Abraham Oommen, Jonathan Twynam-Perkins, Steff Lewis, Steve Cunningham | |
| 2024-05-30 | [Comment] Oral corticosteroids for acute preschool wheeze | Heidi Makrinioti | |
| 2024-05-30 | [Comment] New framework to define the spectrum of tuberculosis | Keertan Dheda, Giovanni Battista Migliori | |
| 2024-05-30 | [Position Paper] Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise | Anna K Coussens, Syed M A Zaidi, Brian W Allwood, Puneet K Dewan, Glenda Gray, Mikashmi Kohli, Tamara Kredo, Ben J Marais, Guy B Marks, Leo Martinez, Morten Ruhwald, Thomas J Scriba, James A Seddon, Phumeza Tisile, Digby F Warner, Robert J Wilkinson, Hani | |
| 2024-05-30 | [Comment] Systematic endoscopic staging of mediastinum in locally advanced NSCLC: a SEISMIC change? | Angela Botticella, Antonin Levy, Cécile Le Pechoux | |
| 2024-05-30 | [Articles] Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial | Daniel P Steinfort, Gargi Kothari, Neil Wallace, Nicholas Hardcastle, Kanishka Rangamuwa, Edith M T Dieleman, Percy Lee, Peixuan Li, Julie A Simpson, Shaun Yo, Farzad Bashirdazeh, Phan Nguyen, Barton R Jennings, David Fielding, Laurence Crombag, Louis B I | |
| 2024-05-01 | [Correspondence] The persistent mismeasure of spirometry in women | Philippe Haouzi, Johnathan McCully | |
| 2024-05-01 | [Corrections] Correction to Lancet Respir Med 2023; 11: 1064–74 | | |
| 2024-05-01 | [Editorial] Lung transplant donors: barriers and ethical considerations | The Lancet Respiratory Medicine | |
| 2024-05-01 | [Correspondence] Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway | Nhung TH Trinh, Annika M Jödicke, Martí Català, Núria Mercadé-Besora, Saeed Hayati, Angela Lupattelli, Daniel Prieto-Alhambra, Hedvig ME Nordeng | |
| 2024-05-01 | [Spotlight] UK patient with multidrug-resistant tuberculosis | Tony Kirby | |
| 2024-05-01 | [Comment] “Yes! We can end TB,” but remember the sequelae in children | Esin Nkereuwem, Marieke M van der Zalm, Beate Kampmann, Toyin Togun | |
| 2024-05-01 | [Comment] Genetic factors for ILD—the path of precision medicine | Ganesh Raghu, Juliet M Torres, Robin L Bennett | |
| 2024-05-01 | [Articles] Association of active mobilisation variables with adverse events and mortality in patients requiring mechanical ventilation in the intensive care unit: a systematic review and meta-analysis | Michelle Paton, Sarah Chan, Ary Serpa Neto, Claire J Tipping, Anne Stratton, Rebecca Lane, Lorena Romero, Tessa Broadley, Carol L Hodgson | |
| 2024-05-01 | [Comment] Early mobilisation in the intensive care unit: shifting from navigating risks to a patient-centred approach | Hannah Wozniak, Michelle E Kho, Eddy Fan | |
| 2024-05-01 | [Comment] MACE in COPD: addressing cardiopulmonary risk | John R Hurst, Chris P Gale, Global Working Group on Cardiopulmonary Risk | |
| 2024-05-01 | [Comment] Corticosteroids in septic shock secondary to community acquired pneumonia: clarity mixed with uncertainty | Balasubramanian Venkatesh, Jeremy Cohen | |
| 2024-05-01 | [Articles] Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial | Nicholas Heming, Alain Renault, Emmanuelle Kuperminc, Christian Brun-Buisson, Bruno Megarbane, Jean-Pierre Quenot, Shidasp Siami, Alain Cariou, Xavier Forceville, Carole Schwebel, Marc Leone, Jean-Francois Timsit, Benoît Misset, Mohamed Ali Benali, Gwenha | |
| 2024-05-01 | [Articles] First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial | Hua Zhong, Shengjie Sun, Jianhua Chen, Ziping Wang, Yanqiu Zhao, Guojun Zhang, Gongyan Chen, Ming Zhou, Jianying Zhou, Yingying Du, Lin Wu, Zhi Xu, Xiaodong Mei, Weidong Zhang, Jingdong He, Jiuwei Cui, Zhihong Zhang, Hui Luo, Weiyou Liu, Meili Sun, Jingxu | |
| 2024-05-01 | [Articles] Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial | Yin Mo, Suchart Booraphun, Andrew Yunkai Li, Pornanan Domthong, Gyan Kayastha, Yie Hui Lau, Ploenchan Chetchotisakd, Direk Limmathurotsakul, Paul Anantharajah Tambyah, Ben S Cooper, REGARD-VAP investigators | |
| 2024-05-01 | [Comment] Optimising antibiotic treatment duration in ventilator-associated pneumonia | Emma D Johnson, James D Chalmers | |
| 2024-05-01 | [Articles] Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial | Claire Dahyot-Fizelier, Sigismond Lasocki, Thomas Kerforne, Pierre-Francois Perrigault, Thomas Geeraerts, Karim Asehnoune, Raphaël Cinotti, Yoann Launey, Vincent Cottenceau, Marc Laffon, Thomas Gaillard, Matthieu Boisson, Camille Aleyrat, Denis Frasca, Ol | |
| 2024-05-01 | [Comment] Antibiotic prophylaxis for patients with acute brain injury | Michael Klompas | |
| 2024-05-01 | [Position Paper] High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study | Sujal R Desai, Nishanth Sivarasan, Kerri A Johannson, Peter M George, Daniel A Culver, Anand Devaraj, David A Lynch, David Milne, Elisabetta Renzoni, Hilario Nunes, Nicola Sverzellati, Paolo Spagnolo, Robert P Baughman, Ruchi Yadav, Sara Piciucchi, Simon | |
| 2024-03-27 | [Comment] Retraction and republication—Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study | The Editors of The Lancet Respiratory Medicine | |
| 2024-03-27 | [Comment] MERIT reloaded—what has changed in CTEPH management since 2017? | Adam Torbicki, Marcin Kurzyna | |
| 2024-03-27 | [Articles] Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study | Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, Peter Fedullo, Luke S Howard, Xavier Jaïs, David P Jenkins, Zhi-Cheng Jing, Michael M Madani, Nicolas Martin, Eckhard Mayer, Kelly Papadakis, Dominik Richard, Nick H Kim, MERIT study investi | |
| 2024-03-27 | [Editorial] Ending tuberculosis: ways forward | The Lancet Respiratory Medicine | |
| 2024-03-27 | [Comment] Improving rural intensive care infrastructure in the USA | Tarun Ramesh, Michael Klompas, Hao Yu | |
匿名用户只展示最新 100 条榜单历史，更多历史数据请登录后查看，支持时光机按天筛选
Sponsors
